Naftopidil


Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 72.7%
Hypertonic Bladder 9.1%
Product Used For Unknown Indication 9.1%
Prostate Cancer 9.1%
Pseudolymphoma 80.0%
Dyspnoea 20.0%
Concomitant
Benign Prostatic Hyperplasia 14.0%
Prostate Cancer Stage Iv 13.6%
Drug Use For Unknown Indication 11.4%
Hypertension 8.8%
Prostate Cancer 7.5%
Prostate Cancer Stage Ii 5.6%
Pancreatitis Acute 5.2%
Product Used For Unknown Indication 4.7%
Rheumatoid Arthritis 4.1%
Asthma 3.2%
Gastritis 3.0%
Dysuria 2.6%
Gastric Cancer 2.4%
Bladder Cancer 2.2%
Insomnia 2.2%
Sepsis 2.2%
Adverse Event 2.1%
Cancer Pain 1.7%
Hyperuricaemia 1.7%
Neurogenic Bladder 1.7%
Pneumonia Aspiration 9.6%
Prostate Cancer 9.6%
Pseudolymphoma 9.6%
Renal Impairment 8.4%
Pancreatitis Acute 6.0%
Retroperitoneal Abscess 6.0%
Interstitial Lung Disease 4.8%
Pollakiuria 4.8%
Prostatic Specific Antigen Increased 4.8%
B-cell Lymphoma 3.6%
Drug Eruption 3.6%
Insomnia 3.6%
Pyrexia 3.6%
Unevaluable Event 3.6%
Urinary Tract Infection 3.6%
Visual Acuity Reduced 3.6%
Wheezing 3.6%
Cardiac Failure 2.4%
Hepatic Function Abnormal 2.4%
Hypertonic Bladder 2.4%

Drug Data